Literature DB >> 6122739

Lymphadenopathy mimicking lymphoma associated with cryoglobulinaemia and arteritis.

D N Slater, A G Messenger, S S Bleehen, L Harvey, B W Hancock.   

Abstract

Two patients are described with polyclonal IgG cryoglobulinaemia and necrotizing arteritis who developed severe lymphadenopathy which clinically mimicked malignant lymphoma. Histological studies demonstrated that the lymphadenopathy resulted from a pseudolymphomatous reaction associated with vascular damage.

Entities:  

Mesh：

Year:  1982        PMID： 6122739      PMCID： PMC1437779          DOI： 10.1177/014107688207500511

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


  7 in total

1.  Mixed IgM-IgG cryoglobulinemia terminating in polyarteritis nodosa.

Authors:  B M Schimmer; K J Bloch
Journal:  J Rheumatol       Date:  1975-06       Impact factor: 4.666

2.  Kawasaki disease. Relationship with infantile periarteritis nodosa.

Authors:  N Tanaka; K Sekimoto; S Naoe
Journal:  Arch Pathol Lab Med       Date:  1976-02       Impact factor: 5.534

3.  Cryoglobulins in vasculitis.

Authors:  J J Cream
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

Review 4.  Cryoimmunoglobulins.

Authors:  H M Grey; P F Kohler
Journal:  Semin Hematol       Date:  1973-04       Impact factor: 3.851

5.  Biologic and clinical significance of cryoglobulins. A report of 86 cases.

Authors:  J C Brouet; J P Clauvel; F Danon; M Klein; M Seligmann
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

6.  Urticaria and arthralgias as manifestations of necrotizing angiitis (vasculitis).

Authors:  N A Soter; K F Austen; I Gigli
Journal:  J Invest Dermatol       Date:  1974-12       Impact factor: 8.551

Review 7.  Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients.

Authors:  P D Gorevic; H J Kassab; Y Levo; R Kohn; M Meltzer; P Prose; E C Franklin
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.